Cholangiocarcinoma — Trials

Cholangiocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

760 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 210
Recruiting: 120
Ph III recruiting: 7
Growth YoY: +17.4%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (106)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06910670	Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid	active not recruiting	N/A	197	Washington University School of MedicineOTHER	1	Sep 25, 2026	clinicaltrials
NCT02757859	WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer	active not recruiting	N/A	845	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER	1	May 29, 2026